Skip to content

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

To keep going please Log in.

or

By submitting my information, I agree to the Privacy Policy and Terms of Service.

MRKR Marker Therapeutics, Inc. Common Stock
$1.30 -2.26% -0.03
Notify me if price changes either direction
Interactive Brokers Logotype

Buy MRKR stocks now with Interactive Brokers – the most advanced investment platform

Contents
  • Performance
  • Key stats
  • Financials
  • US politician trades
Loading

Key Stats

Market cap. 21.7M
Enterprise value 11.5M
Trailing PE -1.6582277756703
Forward PE -2.4528303
PEG Ratio 0.027637129594505
Enterprise to EBITDA -0.96053163860684
Enterprise to revenue 3.246
Price to book MRQ 1.7808218
Price to sales TTM 6.1113863

Financials

Fiscal Year Ends 2025-12-31
Most Recent Quarter (MRQ) 2026-03-31
Revenue (TTM) 3.5M
Diluted EPS TTM -0.38
Total Cash (MRQ) 11.3M
Current ratio (MRQ) 6.027
Operating Cash Flow (TTM) -9756497

MRKR trades by the US politicians

Percentage
0% 0 sells
100% 0 buys
Amount
$0 0 sells
$0 0 buys
In the last 0 months

Recent MRKR News

Home

IMPORTANT NOTICE

Finbold is a news and information website. This Site may contain sponsored content, advertisements, and third-party materials, for which Finbold expressly disclaims any liability.

RISK WARNING: Cryptocurrencies are high-risk investments and you should not expect to be protected if something goes wrong. Don’t invest unless you’re prepared to lose all the money you invest. (Click here to learn more about cryptocurrency risks.)

By accessing this Site, you acknowledge that you understand these risks and that Finbold bears no responsibility for any losses, damages, or consequences resulting from your use of the Site or reliance on its content. Click here to learn more.